Sugi Predict

Sugi Predict / Compounds / SCHEMBL2006138

SCHEMBL2006138

SCHEMBL2006138

Cc1ccc2c(c1)c(C(=O)c1nc(-c3ccccc3)no1)cn2Cc1ccc(Cl)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.44
▸ TP53 P04637 7/20 0.43
▸ LMNA P02545 4/20 0.41
▸ GAA P10253 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ THRB P10828 1/20 0.40
▸ NPSR1 Q6W5P4 5/20 0.40
▸ TSHR P16473 4/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ ALOX15 P16050 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2011508 0.92 TP53 (0.47) MAPTTP53LMNAGAASMN1; SMN2
SCHEMBL2001881 0.91 GSK3B (0.42) MAPTTP53LMNAGAASMN1; SMN2
SCHEMBL2000893 0.90 MAPT (0.47) MAPTTP53LMNAGAASMN1; SMN2
SCHEMBL2005100 0.90 LMNA (0.48) MAPTTP53LMNAGAASMN1; SMN2
SCHEMBL2003646 0.90 MAPT (0.42) MAPTTP53LMNAGAASMN1; SMN2
SCHEMBL2006646 0.89 MAPT (0.40) MAPTTP53LMNAGAASMN1; SMN2
SCHEMBL2006661 0.89 MAPT (0.42) MAPTTP53LMNAGAASMN1; SMN2
SCHEMBL2005397 0.86 MAPT (0.39) MAPTTP53LMNAGAASMN1; SMN2
SCHEMBL2009446 0.85 MAPT (0.42) MAPTTP53LMNAGAASMN1; SMN2
SCHEMBL2004804 0.85 MAPT (0.39) MAPTTP53LMNAGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 — — US disclosed
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 — — US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 — — EP disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 — — US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 — — US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 — — US disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 — — US disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 — — US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 — — US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 MAPT 997/4885TP53 2579/4885LMNA 3450/4885
US-20090264653-A1 USEFUL INDOLE COMPOUNDS FAAH, FAAH2, AANAT MAPT 3753/4885TP53 4264/4885LMNA 4536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.